{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:47:49Z","timestamp":1788871669110,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":415,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK52025"],"award-info":[{"award-number":["DK52025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM60905"],"award-info":[{"award-number":["GM60905"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000985","name":"Assisi Foundation of Memphis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000985","id-type":"DOI","asserted-by":"crossref"}]},{"name":"American Lebanese Syrian Associated Charities (ALSAC)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbadis.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T14:19:34Z","timestamp":1371046774000},"page":"1784-1792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis"],"prefix":"10.1016","volume":"1832","author":[{"given":"Erik J.","family":"Bonten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouri","family":"Yogalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elida","family":"Gomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diantha","family":"van de Vlekkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"d'Azzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.06.002_bb0005","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/emboj\/17.6.1588","article-title":"Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein\/cathepsin A","volume":"17","author":"van der Spoel","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0010","doi-asserted-by":"crossref","first-page":"37657","DOI":"10.1074\/jbc.M007380200","article-title":"Lysosomal neuraminidase. Catalytic activation in insect cells is controlled by the protective protein\/cathepsin A","volume":"275","author":"Bonten","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0015","doi-asserted-by":"crossref","first-page":"28430","DOI":"10.1074\/jbc.M109.031419","article-title":"Heterodimerization of the sialidase NEU1 with the chaperone protective protein\/cathepsin A prevents its premature oligomerization","volume":"284","author":"Bonten","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0020","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1101\/gad.10.24.3156","article-title":"Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis","volume":"10","author":"Bonten","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0025","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/hmg\/9.18.2715","article-title":"Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis","volume":"9","author":"Bonten","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.10268","article-title":"Molecular pathology of NEU1 gene in sialidosis","volume":"22","author":"Seyrantepe","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(88)90999-3","article-title":"Expression of cDNA encoding the human \u201cprotective protein\u201d associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases","volume":"54","author":"Galjart","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0040","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1016\/S0021-9258(18)98751-X","article-title":"Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function","volume":"266","author":"Galjart","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0045","first-page":"3811","article-title":"Galactosialidosis","volume":"vol. 3","author":"d'Azzo","year":"2001"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0050","series-title":"Protective Protein Cathepsin A (PPCA), Wiley Encyclopedia of Molecular Medicine","first-page":"2624","author":"d'Azzo","year":"2002"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1042\/BST0381453","article-title":"Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease","volume":"38","author":"d'Azzo","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0060","first-page":"3507","article-title":"Disorders of glycoprotein degradation and structure: a-mannosidosis, b-mannosidosis, fucosidosis, and sialidosis","volume":"vol. III","author":"Thomas","year":"2001"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0065","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00415-009-5213-4","article-title":"Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients","volume":"256","author":"Caciotti","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities and the development of neurological disorders","volume":"6","author":"Conzelmann","year":"1983","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0075","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0955-0674(91)90035-W","article-title":"Molecular recognition and targeting of lysosomal proteins","volume":"3","author":"von Figura","year":"1991","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0080","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/hmg\/11.12.1455","article-title":"Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice","volume":"11","author":"de Geest","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.devcel.2008.05.005","article-title":"Neuraminidase 1 is a negative regulator of lysosomal exocytosis","volume":"15","author":"Yogalingam","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0090","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbadis.2010.04.002","article-title":"Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue","volume":"1802","author":"Zanoteli","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbadis.2009.10.008","article-title":"Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice","volume":"1802","author":"Wu","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","article-title":"Enzyme replacement therapy for lysosomal diseases: lessons from 20years of experience and remaining challenges","volume":"13","author":"Desnick","year":"2012","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488911794079127","article-title":"Recent developments in therapeutic approaches for lysosomal storage diseases","volume":"6","author":"Urbanelli","year":"2011","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","author":"Valenzano","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0115","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/138920111798376932","article-title":"Substrate reduction therapies for mucopolysaccharidoses","volume":"12","author":"Jak\u00f3bkiewicz-Banecka","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0120","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1093\/hmg\/ddr112","article-title":"Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?","volume":"20","author":"Hawkins-Salsbury","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/mt.2011.227","article-title":"Preclinical dose-finding study with a liver-tropic, recombinant AAV-2\/8 vector in the mouse model of galactosialidosis","volume":"20","author":"Hu","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0130","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jcp.1041250307","article-title":"Transformation of mouse bone marrow cells by transfection with a human oncogene related to c-myc is associated with the endogenous production of macrophage colony stimulating factor 1","volume":"125","author":"Sklar","year":"1985","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0140","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1096\/fj.03-0941fje","article-title":"Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis","volume":"18","author":"Bonten","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbagen.2009.01.006","article-title":"Protective protein\/cathepsin A rescues N-glycosylation defects in neuraminidase-1","volume":"1790","author":"Wang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0150","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1101\/gad.9.21.2623","article-title":"Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells","volume":"9","author":"Zhou","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0155","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1067081","article-title":"Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors","volume":"295","author":"Lois","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0092-8674(87)90584-8","article-title":"Position-independent, high-level expression of the human b-globin gene in transgenic mice","volume":"51","author":"Grosveld","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0165","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/hum.2010.202","article-title":"Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial","volume":"22","author":"Allay","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0180","series-title":"Genetic Metabolic Disease: Diagnosis and Prenatal Analysis","author":"Galjaard","year":"1980"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood.V98.5.1289","article-title":"Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor","volume":"98","author":"Levesque","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0190","doi-asserted-by":"crossref","first-page":"14880","DOI":"10.1073\/pnas.95.25.14880","article-title":"Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein\/cathepsin A under control of the colony-stimulating factor-1 receptor promoter","volume":"95","author":"Hahn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/hmg\/7.2.313","article-title":"A point mutation in the neu-1 locus causes the neuraminidase defect in the SM\/J mouse","volume":"7","author":"Rottier","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-1119(03)00808-4","article-title":"Characterization of the mouse lysosomal sialidase promoter","volume":"319","author":"Champigny","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.bbadis.2013.06.002_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2008.10.017","article-title":"Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period","volume":"96","author":"Ogawa","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2013.06.002_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2005.03.007","article-title":"Short-term, high dose enzyme replacement therapy in sialidosis mice","volume":"85","author":"Wang","year":"2005","journal-title":"Mol. Genet. Metab."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391300210X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391300210X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T19:01:18Z","timestamp":1645729278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544391300210X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S092544391300210X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.06.002","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}